Our CEO Tuvik Beker presented a talk titled, “ENLIGHT: Predicting response to cancer therapy based on gene expression patterns from RNAseq or H&E slides.”
Back
Back
Our CEO Tuvik Beker presented a talk titled, “ENLIGHT: Predicting response to cancer therapy based on gene expression patterns from RNAseq or H&E slides.”